» Articles » PMID: 35281598

Plants in Anticancer Drug Discovery: From Molecular Mechanism to Chemoprevention

Abstract

Cancer is one of the primary causes of mortality globally, and the discovery of new anticancer drugs is the most important need in recent times. Natural products have been recognized as effective in fight against various diseases including cancer for over 50 years. Plants and microbes are the primary and potential sources of natural compounds to fight against cancer. Moreover, researches in the field of plant-based natural compounds have moved towards advanced and molecular level understandings from the last few decades, leading to the development of potent anticancer agents. Also, plants have been accepted as abundant and prosperous sources for the development of novel therapeutic agents for the management and prevention of different cancer types. The high toxicity of some cancer chemotherapy drugs, as well as their unfavorable side effects and drugs resistance, drives up the demand for natural compounds as new anticancer drugs. In this detailed evidence-based mechanistic review, facts and information about various medicinal plants, their bioactive compounds with their potent anticancer activities against different cancers have been gathered, with further approach to represent the molecular mechanism behind the anticancer activity of these plants. This review will be beneficial for investigators/scientists globally involved in the development of natural, safe, effective, and economical therapeutic agents/drugs against various cancers. This might be an important contribution in the field of drug discovery, where drugs can be used alone or in combination to increase the efficacy of newly synthesized drugs.

Citing Articles

Exploring the Therapeutic Potential for Breast Cancer of Phytochemicals and Secondary Metabolites in Marjoram, Thyme, and Persimmon.

Mattingly A, Vickery Z, Ivankovic D, Farrell C, Hakonarson H, Nguyen K Metabolites. 2024; 14(12).

PMID: 39728433 PMC: 11678518. DOI: 10.3390/metabo14120652.


Antioxidant, anti-prostate cancer potential, and phytochemical composition of the ethyl acetate stem bark extract of Boascia coriacea (Pax.).

Moriasi G, Ngugi M, Mwitari P, Omwenga G PLoS One. 2024; 19(12):e0309258.

PMID: 39621623 PMC: 11611185. DOI: 10.1371/journal.pone.0309258.


Molecular Targets of Plant-Derived Bioactive Compounds in Oral Squamous Cell Carcinoma.

Mitea G, Schroder V, Iancu I, Miresan H, Iancu V, Bucur L Cancers (Basel). 2024; 16(21).

PMID: 39518052 PMC: 11545343. DOI: 10.3390/cancers16213612.


Phytochemical analysis, antioxidant, anticancer, and antibacterial potential of (L.) rhizome.

Aziz I, Alfuraydi A, Almarfadi O, Aboul-Soud M, Alshememry A, Alsaleh A Heliyon. 2024; 10(17):e37196.

PMID: 39286191 PMC: 11403495. DOI: 10.1016/j.heliyon.2024.e37196.


Biotransformation of selected secondary metabolites by Alternaria species and the pharmaceutical, food and agricultural application of biotransformation products.

Tembeni B, Idowu O, Benrkia R, Boutahiri S, Olatunji O Nat Prod Bioprospect. 2024; 14(1):46.

PMID: 39158793 PMC: 11333692. DOI: 10.1007/s13659-024-00469-5.


References
1.
Kampan N, Madondo M, McNally O, Quinn M, Plebanski M . Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer. Biomed Res Int. 2015; 2015:413076. PMC: 4475536. DOI: 10.1155/2015/413076. View

2.
Rohena C, Mooberry S . Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities. Nat Prod Rep. 2014; 31(3):335-55. PMC: 4167679. DOI: 10.1039/c3np70092e. View

3.
Upadhyay A, Kumar K, Kumar A, Mishra H . Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) - validation of the Ayurvedic pharmacology through experimental and clinical studies. Int J Ayurveda Res. 2010; 1(2):112-21. PMC: 2924974. DOI: 10.4103/0974-7788.64405. View

4.
Mousavi S, Hashemi S, Behbudi G, Mazraedoost S, Omidifar N, Gholami A . A Review on Health Benefits of L. Nutritional Compounds for Metabolites, Antioxidants, and Anti-Inflammatory, Anticancer, and Antimicrobial Applications. Evid Based Complement Alternat Med. 2021; 2021:5548404. PMC: 8382527. DOI: 10.1155/2021/5548404. View

5.
Ohue Y . [Current Topics of Cancer Antigen]. Gan To Kagaku Ryoho. 2019; 46(10):1467-1472. View